Shyam Sundhar Bale
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shyam Sundhar Bale has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Martin L. Yarmush
Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA
2 shared publications - Anandh Swaminathan
California Institute of Technology
1 shared publication - Bote Gosse Bruinsma
Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
1 shared publication - Gautham Vivek Sridharan
Center for Engineering in Medicine, Harvard Medical School, Massachusetts General Hospital & Shriners Hospital for Children, 51 Blossom Street, Boston, MA 02114, USA
1 shared publication - Korkut Uygun
Center for Engineering in Medicine, Harvard Medical School, Boston, MA
1 shared publication - Laura Moore
Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School and Shriners Hospital for Children , Boston, Massachusetts
1 shared publication
Latest Publications
- Open Access
- 13 November 2017
- Published by MDPI AG in Metabolites
- Vol. 7 (4) , 58
Metabolomic Modularity Analysis (MMA) to Quantify Human Liver Perfusion Dynamics
Large-scale -omics data are now ubiquitously utilized to capture and interpret global responses to perturbations in biological systems, such as the impact of disease states on cells, tissues, and whole organs. Metabolomics data, in particular, are difficult to interpret for providing physiological insight because predefined biochemical pathways used for analysis are inherently biased and fail to capture more complex network interactions that span multiple canonical pathways. In this study, we introduce a nov-el approach coined Metabolomic Modularity Analysis (MMA) as a graph-based algorithm to systematically identify metabolic modules of reactions enriched with metabolites flagged to be statistically significant. A defining feature of the algorithm is its ability to determine modularity that highlights interactions between reactions mediated by the production and consumption of cofactors and other hub metabolites. As a case study, we evaluated the metabolic dynamics of discarded human livers using time-course metabolomics data and MMA to identify modules that explain the observed physiological changes leading to liver recovery during subnormothermic machine perfusion (SNMP). MMA was performed on a large scale liver-specific human metabolic network that was weighted based on metabolomics data and identified cofactor-mediated modules that would not have been discovered by traditional metabolic pathway analyses.
- 13 November 2017
- Published by MDPI AG in Metabolites
- Vol. 7 (4) , 58
Open AccessMetabolomic Modularity Analysis (MMA) to Quantify Human Liver Perfusion Dynamics
Large-scale -omics data are now ubiquitously utilized to capture and interpret global responses to perturbations in biological systems, such as the impact of disease states on cells, tissues, and whole organs. Metabolomics data, in particular, are difficult to interpret for providing physiological insight because predefined biochemical pathways used for analysis are inherently biased and fail to capture more complex network interactions that span multiple canonical pathways. In this study, we introduce a nov-el approach coined Metabolomic Modularity Analysis (MMA) as a graph-based algorithm to systematically identify metabolic modules of reactions enriched with metabolites flagged to be statistically significant. A defining feature of the algorithm is its ability to determine modularity that highlights interactions between reactions mediated by the production and consumption of cofactors and other hub metabolites. As a case study, we evaluated the metabolic dynamics of discarded human livers using time-course metabolomics data and MMA to identify modules that explain the observed physiological changes leading to liver recovery during subnormothermic machine perfusion (SNMP). MMA was performed on a large scale liver-specific human metabolic network that was weighted based on metabolomics data and identified cofactor-mediated modules that would not have been discovered by traditional metabolic pathway analyses.
- 1 October 2016
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
- Vol. 22 (5) , 383-394
Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions
In vitro liver models provide essential information for evaluating drug metabolism, metabolite formation, and hepatotoxicity. Interfacing liver models with other organ models could provide insights into the desirable as well as unintended systemic side effects of therapeutic agents and their metabolites. Such information is invaluable for drug screening processes particularly in the context of secondary organ toxicity. While interfacing of liver models with other organ models has been achieved, platforms that effectively provide human-relevant precise information are needed. In this concise review, we discuss the current state-of-the-art of liver based multi-organ cell culture platforms primarily from a drug and metabolite perspective; and highlight the importance of cell-to-media ratio in interfacing liver models with other organ models. In addition, we briefly discuss issues related to development of optimal liver models that include recent advances in hepatic cell lines, stem cells and challenges associated with primary hepatocyte-based liver models. Liver based multi-organ models that achieve physiologically relevant coupling of different organ models can have a broad impact in evaluating drug efficacy and toxicity, as well as mechanistic investigation of human relevant disease conditions.
- 1 October 2016
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
- Vol. 22 (5) , 383-394
Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions
In vitro liver models provide essential information for evaluating drug metabolism, metabolite formation, and hepatotoxicity. Interfacing liver models with other organ models could provide insights into the desirable as well as unintended systemic side effects of therapeutic agents and their metabolites. Such information is invaluable for drug screening processes particularly in the context of secondary organ toxicity. While interfacing of liver models with other organ models has been achieved, platforms that effectively provide human-relevant precise information are needed. In this concise review, we discuss the current state-of-the-art of liver based multi-organ cell culture platforms primarily from a drug and metabolite perspective; and highlight the importance of cell-to-media ratio in interfacing liver models with other organ models. In addition, we briefly discuss issues related to development of optimal liver models that include recent advances in hepatic cell lines, stem cells and challenges associated with primary hepatocyte-based liver models. Liver based multi-organ models that achieve physiologically relevant coupling of different organ models can have a broad impact in evaluating drug efficacy and toxicity, as well as mechanistic investigation of human relevant disease conditions.